AP NEWS

Global Biosimilars Strategic Business Report 2018 - ResearchAndMarkets.com

September 19, 2018

DUBLIN--(BUSINESS WIRE)--Sep 19, 2018--The “Biosimilars - Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. This report analyzes the worldwide markets for Biosimilars in US$ Million.

The report profiles 71 companies including many key and niche players such as:

Allergan Plc (Ireland) Amgen, Inc. (USA) Biocon Ltd. (India) Biopartners GmbH (Switzerland) Boehringer Ingelheim International GmbH (Germany) Celltrion, Inc. (South Korea) Dr. Reddy’s Laboratories Ltd. (India) Eli Lilly and Company (USA) Fresenius Kabi (Germany) Intas Pharmaceuticals Ltd. (India) Mylan N.V. (USA) Pfizer, Inc. (USA) Samsung Bioepis Co., Ltd. (Korea) Sandoz International GmbH (Germany) STADA Arzneimittel AG (Germany) Teva Pharmaceutical Industries Ltd. (Israel)

Key Topics Covered:

1. Introduction, Methodology & Product Definitions

2. Industry Overview

3. Noteworthy Market Trends, Growth Drivers & Issues

4. Product Overview

5. Competitive Landscape

6. Global Market Perspective

7. Regional Market Perspective

8. Company Profiles

Total Companies Profiled: 71 (including Divisions

Subsidiaries - 77)

The United States (15) Canada (1) Japan (3) Europe (26) France (1)Germany (8)The United Kingdom (5)Spain (1)Rest of Europe (11) Asia-Pacific (Excluding Japan) (29) Middle East (2) Latin America (1) For more information about this report visit https://www.researchandmarkets.com/research/wdw3vc/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005335/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biosimilars and Biosuperiors

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/19/2018 06:52 AM/DISC: 09/19/2018 06:52 AM

http://www.businesswire.com/news/home/20180919005335/en

AP RADIO
Update hourly